# Ready to update draft PR

Gate: ready-to-open-draft-PR. Work unit sub-agents-defaults; continuation of PR #50 on feat/sub-agent-result-collection. Base ebd547fab97a5af3f3bcffae7ebb187b71563dcf.

## Entry checks and decision

- Clean worktree and intended branch confirmed. The eight commits since base comprise the original result-collection PR and this explicitly authorized continuation; no unrelated source change.
- Accepted plan 1e20493; sole approved S1 accepted b7ac57d; aggregate deepreview/fix/re-review accepted 7101707. All accepted findings 已修复, supported by recorded source reproduction and regression evidence.
- Documentation decision implemented in both READMEs, main SKILL and advanced reference. Ordinary calls use natural task text and optional checks; statistics and actual process lifecycle remain.
- Final focused suite 46 pass. Earlier complete suite 133 tests: 124 pass, nine environment-gated skips; final complete suite is running to cover the subsequent UTF-8 and advisory-classification regression additions. Actual result will be recorded in PR evidence.
- Native Codex/Claude Seatbelt validation after input/path fixes: two pass using deterministic local fixtures, not a provider probe. Last two adapter-only fixes are covered by focused result/preflight tests. Six skill validators and syntax/diff checks pass.
- No issue association: user-requested feature continuation, not a numbered issue. No GitHub comment, approval, merge, reviewer request, ready-for-review transition or live sync authorized.

## Residual risks

No accepted finding is deferred. Semantic truth, required execution proof and artifact content remain owned by caller project and documented in SKILL. Incomplete runtime visibility or interruptions are assigned to maintainer's later result-collection work unit (destination: final closeout risk register). Other consumer migration is outside the user-confirmed scope and only a future work unit if requested. No unclassified risk or blocking question.

Decision: pass. Next: push existing branch; reuse #50 as draft; then PR review of exact published OIDs, not draft-PR-pass.
